Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis

Nayeli Shantal Castrejón-Jiménez; Blanca Estela García-Pérez; Nydia Edith Reyes-Rodríguez; Vicente Vega-Sánchez; Víctor Manuel Martínez-Juárez; Juan Carlos Hernández-González

doi:10.3390/bios12090728

Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis

Nayeli Shantal Castrejón-Jiménez, Blanca Estela García-Pérez, Nydia Edith Reyes-Rodríguez, Vicente Vega-Sánchez, Víctor Manuel Martínez-Juárez, Juan Carlos Hernández-González

Escuela Nacional de Ciencias Biológicas (ENCB)

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

13 Citas (Scopus)

Resumen

SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the coronavirus disease in late 2019 and triggered a pandemic that has severely affected human health and caused millions of deaths. Early and massive diagnosis of SARS-CoV-2 infected patients is the key to preventing the spread of the virus and controlling the outbreak. Lateral flow immunoassays (LFIA) are the simplest biosensors. These devices are clinical diagnostic tools that can detect various analytes, including viruses and antibodies, with high sensitivity and specificity. This review summarizes the advantages, limitations, and evolution of LFIA during the SARS-CoV-2 pandemic and the challenges of improving these diagnostic devices.

Idioma original	Inglés
Número de artículo	728
Publicación	Biosensors
Volumen	12
N.º	9
DOI	https://doi.org/10.3390/bios12090728
Estado	Publicada - sep. 2022

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.3390/bios12090728

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{6f01125caf2748f7b667eb576f7ef87b,

title = "Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis",

abstract = "SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the coronavirus disease in late 2019 and triggered a pandemic that has severely affected human health and caused millions of deaths. Early and massive diagnosis of SARS-CoV-2 infected patients is the key to preventing the spread of the virus and controlling the outbreak. Lateral flow immunoassays (LFIA) are the simplest biosensors. These devices are clinical diagnostic tools that can detect various analytes, including viruses and antibodies, with high sensitivity and specificity. This review summarizes the advantages, limitations, and evolution of LFIA during the SARS-CoV-2 pandemic and the challenges of improving these diagnostic devices.",

keywords = "COVID-19, SARS-CoV-2, antibodies, biosensors, diagnosis, lateral flow immunoassay",

author = "Castrej{\'o}n-Jim{\'e}nez, {Nayeli Shantal} and Garc{\'i}a-P{\'e}rez, {Blanca Estela} and Reyes-Rodr{\'i}guez, {Nydia Edith} and Vicente Vega-S{\'a}nchez and Mart{\'i}nez-Ju{\'a}rez, {V{\'i}ctor Manuel} and Hern{\'a}ndez-Gonz{\'a}lez, {Juan Carlos}",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = sep,

doi = "10.3390/bios12090728",

language = "Ingl{\'e}s",

volume = "12",

journal = "Biosensors",

issn = "2079-6374",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "9",

}

Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis. / Castrejón-Jiménez, Nayeli Shantal; García-Pérez, Blanca Estela; Reyes-Rodríguez, Nydia Edith et al.
En: Biosensors, Vol. 12, N.º 9, 728, 09.2022.

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

TY - JOUR

T1 - Challenges in the Detection of SARS-CoV-2

T2 - Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis

AU - Castrejón-Jiménez, Nayeli Shantal

AU - García-Pérez, Blanca Estela

AU - Reyes-Rodríguez, Nydia Edith

AU - Vega-Sánchez, Vicente

AU - Martínez-Juárez, Víctor Manuel

AU - Hernández-González, Juan Carlos

PY - 2022/9

Y1 - 2022/9

N2 - SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the coronavirus disease in late 2019 and triggered a pandemic that has severely affected human health and caused millions of deaths. Early and massive diagnosis of SARS-CoV-2 infected patients is the key to preventing the spread of the virus and controlling the outbreak. Lateral flow immunoassays (LFIA) are the simplest biosensors. These devices are clinical diagnostic tools that can detect various analytes, including viruses and antibodies, with high sensitivity and specificity. This review summarizes the advantages, limitations, and evolution of LFIA during the SARS-CoV-2 pandemic and the challenges of improving these diagnostic devices.

AB - SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the coronavirus disease in late 2019 and triggered a pandemic that has severely affected human health and caused millions of deaths. Early and massive diagnosis of SARS-CoV-2 infected patients is the key to preventing the spread of the virus and controlling the outbreak. Lateral flow immunoassays (LFIA) are the simplest biosensors. These devices are clinical diagnostic tools that can detect various analytes, including viruses and antibodies, with high sensitivity and specificity. This review summarizes the advantages, limitations, and evolution of LFIA during the SARS-CoV-2 pandemic and the challenges of improving these diagnostic devices.

KW - COVID-19

KW - SARS-CoV-2

KW - antibodies

KW - biosensors

KW - diagnosis

KW - lateral flow immunoassay

UR - http://www.scopus.com/inward/record.url?scp=85138336471&partnerID=8YFLogxK

U2 - 10.3390/bios12090728

DO - 10.3390/bios12090728

M3 - Artículo de revisión

C2 - 36140114

AN - SCOPUS:85138336471

SN - 2079-6374

VL - 12

JO - Biosensors

JF - Biosensors

IS - 9

M1 - 728

ER -

Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto